A 'Laser Phase Plate' Breakthrough Just Made 90% of Human Proteins Visible to Science

For the past decade, structural biology has been dominated by a Nobel Prize-winning technology called cryo-electron microscopy (cryo-EM). By flash-freezing biological samples and bombarding them with electrons, scientists have been able to map the intricate 3D shapes of the molecular machines that keep us alive. But cryo-EM has always harbored a massive blind spot: it struggles to see small things. Because biological specimens are 'weak-phase objects' that generate very little intrinsic image contrast, the electron beam passes through them almost unimpeded. As a result, researchers estimate that more than 90% of the proteins inside human cells are simply too small to generate enough contrast to be imaged clearly.[3][4][6]

That blind spot is now closing. In a landmark achievement published across Science, Nature Communications, and bioRxiv, researchers from UC Berkeley and Biohub have successfully built and integrated a 'laser phase plate' into a state-of-the-art cryo-electron microscope. First proposed more than 15 years ago by physicists Holger Müller and Robert Glaeser, the device was long dismissed by the field as theoretically elegant but practically impossible to build. Today, it is fully operational, dramatically boosting the contrast of small proteins and bringing the invisible machinery of the cell into sharp focus.[1][2][3][5]

The physics behind the breakthrough relies on manipulating the electron beam itself. Inside the microscope, a powerful laser—amplified by highly polished mirrors to be 100 million times brighter than the surface of the sun—is focused directly onto the electron beam. As the electrons pass through this intense field of light, their phase is shifted. This subtle modulation converts invisible phase shifts into detectable intensity variations when the electrons hit the camera sensor, effectively turning up the contrast dial on the microscopic world.[2][3][4]

To prove the technology works, the Berkeley and Biohub teams tested the laser phase plate on hemoglobin, the oxygen-carrying protein in human blood. At roughly 64 kilodaltons, hemoglobin sits at the absolute lower limit of what conventional cryo-EM can resolve; it typically appears as a blurry, indistinct blob. With the laser switched on, the resolution of the hemoglobin structure improved by up to 44%. Features that were previously washed out sharpened into clearly defined atomic architecture, proving that the laser does not trade resolution for contrast.[2][3][6]

The teams also achieved a staggering 1.8-angstrom resolution on apoferritin, an iron-storage protein used as a standard benchmark in the field. This approaches the theoretical resolution limit of the technology, signaling to structural biologists that the laser phase plate is not just a proof-of-concept, but a robust tool ready for rigorous scientific application. The device has been successfully integrated into a custom Thermo Scientific Krios microscope, the dominant, multi-million-dollar workhorse of modern structural biology facilities.[1][5][6]

The implications for medicine and drug discovery are profound. The pharmaceutical industry relies heavily on structure-based drug design: if researchers can see the exact geometric shape of a protein that causes a disease, they can design a custom molecule—a ligand or inhibitor—to bind to it and shut it down. Because conventional cryo-EM could only resolve roughly 10% of the human proteome in purified form, thousands of potential drug targets remained locked in a blurry haze. By bringing these elusive proteins into clear view, the laser phase plate provides a direct path toward designing highly specific therapies with fewer off-target side effects.[4][6]

Beyond isolated proteins, the researchers are already looking toward the next frontier: cryo-electron tomography (cryo-ET). While standard cryo-EM requires proteins to be purified and isolated in a solution, cryo-ET captures 3D reconstructions of proteins in their natural, crowded cellular environment. Currently, fewer than 1% of proteins can be seen clearly in their native state. The laser phase plate is expected to push that number past 50%, allowing scientists to watch how molecular machines assemble, interact, and malfunction in real-time disease states.[3][4][6]

While the technology is currently limited to a few specialized laboratories in California, the successful demonstration marks a paradigm shift in biological imaging. By merging quantum optics with structural biology, scientists have finally overcome the contrast barrier that has held the field back for decades. As the laser phase plate moves toward commercialization and broader adoption, it promises to map the fundamental molecular drivers of human life with unprecedented precision.[1][2][6]